Cargando…

BSBM-22 CHARACTERIZATION OF CIRCULATORY SHEAR STRESS-INDUCED MOLECULAR CHANGES IN LUNG ADENOCARCINOMA CELLS AND IMPLICATIONS IN BRAIN METASTASIS

INTRODUCTION: Lung cancer is the most common tumor to metastasize to the brain, as 40% of patients develop brain metastasis (BM). Once diagnosed, survival is only 6.5-10 months. A potential target to prevent BM is circulating tumor cells (CTCs). The mechanisms that mediate a CTCs adaptation to the h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marenco-Hillembrand, Lina, McKevitt, Chase, Bamimore, Michael, Wickland, Daniel, Schiapparelli, Paula, Maharjan, Sushila, Zhang, Yu Shrike, Quinones-Hinojosa, Alfredo, Chaichana, Kaisorn L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Final Category: Basic Science of Brain Metastases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402317/ http://dx.doi.org/10.1093/noajnl/vdad070.018

Ejemplares similares

BSBM-07 HIGH-DIMENSIONAL HISTOPATHOLOGIC EVALUATION OF THE HYPOXIC MICROENVIRONMENT IN GLIOBLASTOMA
por: Mansouri, Sheila, et al.
Publicado: (2023)

BSBM-06 UNRAVELING THE IMMUNE MICROENVIRONMENT OF BRAIN METASTASIS FROM LUNG ADENOCARCINOMA
por: Souza, Vanessa G P, et al.
Publicado: (2023)

BSBM-10 CHARACTERIZATION OF A RADIATION-RESISTANT MODEL OF LUNG CANCER BRAIN METASTASIS
por: Wolford, Cullen, et al.
Publicado: (2023)

BSBM-17 NOVEL VALIDATED PATIENT-DERIVED MODELS OF A RECTAL CANCER BRAIN METASTASIS
por: Barros Guinle, Maria Isabel, et al.
Publicado: (2023)

BSBM-21 MACHINE LEARNING IDENTIFIES EXPERIMENTAL BRAIN METASTASIS SUBTYPES BASED ON THEIR INFLUENCE ON NEURAL CIRCUITS
por: Masmudi-Martin, Mariam, et al.
Publicado: (2023)

BSBM-14 MOLECULAR PROFILING OF CHECKPOINT LIGANDS AND KEY NK-ACTIVATION AND SUPPRESSIVE LIGANDS BY METASTATIC MELANOMA CELLS
por: Anchan, Akshata, et al.
Publicado: (2023)

BSBM-13 MELANOMA CELLS PRODUCE A SUSPENSION SUB-POPULATION THAT DRASTICALLY DISRUPTS THE BLOOD-BRAIN BARRIER ENDOTHELIUM
por: Anchan, Akshata, et al.
Publicado: (2023)

BSBM-12 STAT3 EXPRESSION IN BRAIN METASTASES FROM BREAST CANCER: CORRELATIONS WITH DIFFERENT MOLECULAR SUBTYPES AND CLINICAL OUTCOME
por: Pellerino, Alessia, et al.
Publicado: (2023)

BSBM-16 HLA CLASS-I ANTIGEN PRESENTATION MACHINERY AND IFN-γ PATHWAY ALTERATIONS IN LUNG CANCER BRAIN METASTASES
por: Vilarino, Noelia, et al.
Publicado: (2023)

BSBM-04 MULTIPLE MYELOMA METASTASIS TO THE PINEAL GLAND: A CASE REPORT FROM LONG ISLAND, NEW YORK, USA
por: Torres, Marielle, et al.
Publicado: (2023)

Circulatory shear stress induces molecular changes and side population enrichment in primary tumor-derived lung cancer cells with higher metastatic potential
por: Alvarado-Estrada, Keila, et al.
Publicado: (2021)

BSBM-15 SYSTEMIC AND LOCAL IMMUNE RESPONSES FOLLOWING STEREOTACTIC RADIOSURGERY TO BRAIN METASTASES FROM HER2-AMPLIFIED BREAST CANCER
por: Sia, Joseph, et al.
Publicado: (2023)

BSBM-03 A NOVEL COMBINED IMMUNOTHERAPY TO IMPROVE THERAPEUTIC RESPONSES IN SYMPTOMATIC BRAIN METASTASIS BASED ON TARGETING A SUBPOPULATION OF IMMUNOSUPPRESSIVE ASTROCYTES
por: Priego, Neibla, et al.
Publicado: (2023)

BSBM-19 CROSS-PRESENTATION BY TUMOR-ASSOCIATED MACROPHAGES MEDIATES THE TRANSITION FROM PROGENITOR TO TERMINAL T CELL EXHAUSTION IN PRIMARY AND METASTATIC BRAIN TUMORS
por: Polania, Jessica Waibl, et al.
Publicado: (2023)

BSBM-11 COMBINING IMMUNOTHERAPY AND WHOLE-BRAIN RADIATION THERAPY IN A NOVEL SYNGENEIC LUNG CANCER BRAIN METASTASIS PRECLINICAL MODEL: DOES TIMING OF ADMINISTRATION MATTER?
por: Blethen, Kathryn, et al.
Publicado: (2023)

BSBM-18 SINGLE-CELL PROFILING TUMOR-INFILTRATING IMMUNE CELLS REVEALS CXCL13(+) FOLLICULAR HELPER-LIKE CD4(+) T CELLS IN HUMAN BRAIN TUMORS
por: Lu, Benjamin, et al.
Publicado: (2023)

BSBM-20 INVESTIGATING THE ROLE OF OXIDATIVE PHOSPHORYLATION (OXPHOS) IN CD4+ T CELL ACTIVATION AND RESPONSE TO ANTI-PD1/ANTI-LAG3 IMMUNOTHERAPY IN MELANOMA BRAIN METASTASIS (MBM)
por: Guerrieri, Renato, et al.
Publicado: (2023)

BSBM-09 IN VIVO CRISPR ACTIVATION SCREEN IDENTIFIES ß-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) AS A DRIVER OF NON-SMALL CELL LUNG CANCER BRAIN METASTASIS
por: Chafe, Shawn, et al.
Publicado: (2023)

BSCI-16. HEMODYNAMIC SHEAR STRESS SELECTS A SUBPOPULATION OF LUNG ADENOCARCINOMA CELLS WITH HIGHER METASTATIC CAPACITY
por: Alvarado-Estrada, Keila N, et al.
Publicado: (2019)

METASTASES-03 PREVALENCE AND CLINICAL SIGNIFICANCE OF UNSUSPECTED INTRACRANIAL FINDINGS IN PATIENTS UNDERGOING ONCOLOGICAL WHOLE BODY(18) F- FLUORODEOXYGLUCOSE (FDG) PET CT IMAGING.
por: Nyamieri, Diana Kerubo, et al.
Publicado: (2023)

METASTASES-01 OUTCOME OF BRAIN METASTASES TREATED WITH GAMMA KNIFE STEREOTACTIC RADIOSURGERY (GKSR): COHORT RETROSPECTIVE STUDY ON 205 CASES
por: Bankole, Nourou Dine Adeniran, et al.
Publicado: (2023)

Supervised machine learning to validate a novel scoring system for the prediction of disease remission of functional pituitary adenomas following transsphenoidal surgery
por: McKevitt, Chase, et al.
Publicado: (2023)

The Evolving Landscape of Leptomeningeal Cancer from Solid Tumors: A Systematic Review of Clinical Trials
por: Marenco-Hillembrand, Lina, et al.
Publicado: (2023)

Contemporary Surgical Management of Deep-Seated Metastatic Brain Tumors Using Minimally Invasive Approaches
por: Marenco-Hillembrand, Lina, et al.
Publicado: (2018)

Patient and implant survival following joint replacement because of metastatic bone disease: A cross-sectional study of 130 patients with 140 joint replacements
por: Sørensen, Michala S, et al.
Publicado: (2013)

TIPS-17 A FIRST-IN-HUMAN FEASIBILITY STUDY TO EVALUATE THE SAFETY OF SELECTIVE INTRA-ARTERIAL YTTRIUM-90 MICROSPHERE TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA (THE FRONTIER TRIAL)
por: Mouli, Samdeep, et al.
Publicado: (2023)

Endoscopic endonasal odontoidectomy for the treatment of basilar invagination
por: Ruiz-Garcia, Henry, et al.
Publicado: (2020)

MDB-17. THE PTBP2 SPLICING FACTOR IS ESSENTIAL IN GROUP 3/4 MEDULLOBLASTOMA
por: Caisova, Veronika, et al.
Publicado: (2023)

NEIM-14 PET/MRI DETECTS A RAPID DECREASE IN CEREBRAL BLOOD FLOW IN GLIOBLASTOMA FOLLOWING BEVACIZUMAB INFUSION
por: Thaw-Poon, Serena, et al.
Publicado: (2023)

NEIM-03 A GRADUAL INTEGRATION MODEL BASED ON MRI TO PREDICT MOLECULAR PROFILES IN PATIENTS WITH GLIOMA
por: Chen, Hongyu, et al.
Publicado: (2023)

NEIM-11 DEUTERIUM METABOLIC IMAGING (DMI) DETECTS A LARGER WARBURG EFFECT IN HIGH-GRADE BRAIN TUMORS AND IN IDH WILD TYPE GLIOMAS
por: Kim, Lauren, et al.
Publicado: (2023)

NEIM-15 AN EXCEPTION TO THE METASTATIC RULE: A NON-ENHANCING MIDBRAIN LESION DUE TO METASTATIC FIBROMYXOID SARCOMA WITH EXTENSIVEINFLAMMATORY INFILTRATE
por: Rogawski, David, et al.
Publicado: (2023)

NEIM-08 MODELING COMPETITION BETWEEN SUBPOPULATIONS WITH VARIABLE DNA CONTENT IN RESOURCE LIMITED MICROENVIRONMENTS
por: Katira, Parag, et al.
Publicado: (2023)

NEIM-05 PURSUE: RESULTS FROM A PROSPECTIVE, PHASE 2B TRIAL TO DEFINE IMAGE INTERPRETATION CRITERIA FOR(18)F-FLUCICLOVINE-PET FOR DETECTION OF RECURRENT BRAIN METASTASES AFTER RADIATION THERAPY
por: Kotecha, Rupesh, et al.
Publicado: (2023)

NEIM-02 CHARACTERIZATION OF LARGE BRAIN METASTASES WITH(18)F-FLUCICLOVINE PET/CT TREATED WITH STAGED STEREOTACTIC RADIOSURGERY (SSRS): INTERIM ANALYSIS OF A PILOT STUDY
por: Rosa, Alonso La, et al.
Publicado: (2023)

NEIM-13 THE PROGNOSTIC ROLE OF VENTRICULAR SIZE AND ITS DYNAMICS IN PATIENTS WITH LEPTOMENINGEAL METASTASIS FROM SOLID TUMORS
por: Le Rhun, Emilie, et al.
Publicado: (2023)

NEIM-07 HARNESSING END-TO-END CLOUD-BASED WORKFLOWS AND MULTI-MODAL DATA ANALYTICS IN PEDIATRIC BRAIN TUMOR IMAGING AT THE CHILDREN’S BRAIN TUMOR NETWORK (CBTN)
por: Nabavizadeh, Ali, et al.
Publicado: (2023)

NEIM-12 PRE- AND POST-TREATMENT RADIOLOGIC FEATURES AND VOLUMETRIC CHANGES LINKED TO TREATMENT RESPONSE OF BRAIN METASTASES AFTER LASER INTERSTITIAL THERMAL THERAPY (LITT)
por: Sanvito, Francesco, et al.
Publicado: (2023)

NEIM-01 IMMUNOSUPPRESSION IN THE GLIOMA MICROENVIRONMENT: USING PET IMAGING TO HIGHLIGHT THE PRESENCE OF TIGIT
por: Frederico, Stephen, et al.
Publicado: (2023)

MENINGIOMA-03 FUNCTIONAL OUTCOME AFTER SURGERY FOR INTRACRANIAL MENINGIOMA AT THE KENYATTA NATIONAL HOSPITAL
por: Kagasi, Travor, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p41jomb0pdubd0j0386me736r8